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Abstract
Background: Throughout Africa, the private retail sector has been recognised as an important source of
antimalarial treatment, complementing formal health services. However, the quality of advice and
treatment at private outlets is a widespread concern, especially with the introduction of artemisinin-based
combination therapies (ACTs). As a result, ACTs are often deployed exclusively through public health
facilities, potentially leading to poorer access among parts of the population. This research aimed at
assessing the performance of the retail sector in rural Tanzania. Such information is urgently required to
improve and broaden delivery channels for life-saving drugs.
Methods: During a comprehensive shop census in the districts of Kilombero and Ulanga, Tanzania, we
interviewed 489 shopkeepers about their knowledge of malaria and malaria treatment. A complementary
mystery shoppers study was conducted in 118 retail outlets in order to assess the vendors' drug selling
practices. Both studies included drug stores as well as general shops.
Results:  Shopkeepers in drug stores were able to name more malaria symptoms and were more
knowledgeable about malaria treatment than their peers in general shops. In drug stores, 52% mentioned
the correct child-dosage of sulphadoxine-pyrimethamine (SP) compared to only 3% in general shops. In
drug stores, mystery shoppers were more likely to receive an appropriate treatment (OR = 9.6), but at
an approximately seven times higher price. Overall, adults were more often sold an antimalarial than
children (OR = 11.3). On the other hand, general shopkeepers were often ready to refer especially
children to a higher level if they felt unable to manage the case.
Conclusion: The quality of malaria case-management in the retail sector is not satisfactory. Drug stores
should be supported and empowered to provide correct malaria-treatment with drugs they are allowed
to dispense. At the same time, the role of general shops as first contact points for malaria patients needs
to be re-considered. Interventions to improve availability of ACTs in the retail sector are urgently required
within the given legal framework.
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Background
Treatment-seeking behaviour for malaria in sub-Saharan
Africa is complex, often involving several steps and actors,
depending on the local health system, society and culture
[1,2]. As a result of poor access to and often poor perform-
ance of formal health services, presumptive treatment of
malaria episodes at home has become a widespread
option [3,4]. The home-management of malaria (HMM)
strategy of the WHO is promoting interventions to
improve antimalarial drug use outside the formal health
services as a complementary option to improve access to
prompt and effective treatment at community level [5].
In most places, the private retail sector has been identified
as an important source of drugs close to people's homes
[6-8]. However, the regimens dispensed by private retail-
ers are often inadequate with regard to the type of drug
and their dosage [9-11]. In order to increase community-
wide effectiveness of antimalarial treatment, the popular-
ity of home-management and the quality of treatment
obtained from commercial shops need to be better
addressed. Considerable improvement in case-manage-
ment has been shown to be possible as a result of training
private retailers in general shops [12] and in drug stores
[13].
In Tanzania, the private retail sector plays a central role in
the provision of malaria treatment, partly complementing
health facility services where these are unable to deliver
[14]. In rural areas, 68% of the population live within 5
km of a health centre or a dispensary (98% in urban areas)
[15]. Yet, poor quality of care, shortage of skilled provid-
ers, stock-outs of essential drugs, and long waiting times
[16,17] may drive patients to seek care (or at least buy
drugs) from more expensive non-governmental facilities,
or from shops. The Tanzanian retail sector for drugs
includes two types of licensed drug stores as well as gen-
eral shops. Fully-fledged pharmacies are allowed to sell all
prescription medicines and need to be headed by a phar-
macist. In 2003, 60% of the 344 existing pharmacies were
located in Dar es Salaam and the rest in other larger towns
[18]. Part II drug stores (in Swahili: Duka la Dawa Baridi)
need to be headed by a person with basic medical or
health-related training and can be found in towns and
larger villages. Part II shops are allowed to sell over-the-
counter (OTC) drugs only (e.g. analgesics/antipyretics). In
practice however, they dispense a much wider variety of
medicines. This usually includes certain antimalarials, all
of which are prescription-only medicines (except for oral
amodiaquine) [19]. In 2003, 5666 registered part II drug
stores were operating in Tanzania [18]. The legal situation
regarding drug sales in general shops was unclear [20]. It
appeared that, while they were not allowed to stock any
drugs, they were often selling common OTC medicines,
such as painkillers (Figure 1).
The studies presented here made use of selected key indi-
cators in a mixed methods approach to compare factual
knowledge with every-day practices of private drug retail-
ers in treating cases of malaria in two Tanzanian districts.
The research aimed to provide an assessment of the qual-
ity of malaria case-management in shops in order to
inform interventions targeted at the retail sector. We
included retailers in drug stores as well as general shops in
Examples of a part II drug store (left) and a general shop (right) Figure 1
Examples of a part II drug store (left) and a general shop (right). Both shop types are providers of malaria treatment 
in rural Tanzania.BMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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order to get a comprehensive picture of the quality of
treatment and advice that can be obtained from shops.
This information is particularly important in the light of
ongoing discussions on suitable distribution channels for
artemisinin-based combination therapies (ACT). The
studies were carried out within the frame of a project to
improve access to prompt and effective malaria treatment
in rural Tanzania (ACCESS Programme) [21].
Methods
Study setting
A systematic shop census and a complementary study
using mystery shoppers were conducted in the districts of
Kilombero and Ulanga, Morogoro Region, south-eastern
Tanzania. The study area comprised the 25 villages of the
local Demographic Surveillance System (DSS) [22] and
the town of Ifakara, 20 km to the east of the DSS. The mid-
2004 population of the DSS was 74,200 and Ifakara had a
population of 45,726 in the 2001 population census [23].
Malaria is highly endemic in the area, accounting for
roughly half of all outpatient visits in rural health facili-
ties. The study area is described in more detail elsewhere
[21]. Previous studies in the same setting found a range of
easily accessible commercial outlets frequently selling
drugs for fever episodes [8]. In 2004, 29 part II drug stores
and 460 general shops stocking drugs were counted and
chloroquine was found to be completely replaced on the
market by sulphadoxine-pyrimethamine (SP) and amodi-
aquine [24].
At the time of the surveys, SP was the recommended first-
line treatment for uncomplicated malaria; amodiaquine
and quinine were second-line and third-line treatment,
respectively. Quinine was the drug of choice for severe
malaria [25]. All antimalarials were prescription-only
medicines and could therefore legally be sold only in the
one registered pharmacy located in Ifakara town. How-
ever, part II drug stores which were found in some villages
were generally tolerated to stock and sell antimalarials.
General shops were not allowed to stock any prescription
drugs, which was reflected in the low availability of anti-
malarials reported elsewhere [24].
Shop census
Between May and June 2004, all commercial outlets in the
DSS area and Ifakara town were visited in order to investi-
gate the availability of antimalarial drugs in the retail sec-
tor. The detailed methodology of this census, as well as
the results on drug availability have been published else-
where [24]. This paper makes use of additional informa-
tion on shopkeepers' knowledge of malaria and its
treatment, collected during the same survey. Interviews
were carried out with shopkeepers or acting drug vendors
if the shopkeepers were not present. They were asked to
name signs and symptoms of "malaria" and to explain the
recommended treatment of "uncomplicated malaria" in
children of two years of age and adults. We used the terms
"malaria" and "uncomplicated malaria" (in Swahili:
malaria isiyo kali) in the same was as they were used in
information materials produced by the National Malaria
Control Programme. In addition, the interviewers
recorded information on the estimated number of cus-
tomers per day.
Mystery shoppers
The results of the census were complemented in Septem-
ber and October 2004 by "mystery shoppers", simulated
clients who purchased drugs for predefined malaria case-
scenarios.
From a preliminary list of outlets stocking drugs in 2004
(n = 510), a sample of approx. 20% (111) of all general
shops was chosen at random. The sample size was defined
mainly on the basis of operational considerations. The
sample was drawn per village and weighed by village size.
A back-up sample was drawn to compensate for shops
that would be closed or could not be visited for other rea-
sons. In addition, all 19 drug stores from the DSS area and
10 from Ifakara town were added to the sample.
One of the following three case scenarios was randomly
assigned to each of the sampled shops.
(A) child aged 2–4 months, with fever/hot body for one
day and problems with drinking/breastfeeding
(B) child aged 2–4 years, with recurring fever/hot body for
3 days (especially at night), problems with drinking and
eating, diarrhoea and tiredness/not playing as usual
(C) adult, with recurring fever/hot body for 2 days, head-
ache, dizziness and loss of appetite.
The scenarios were developed based on the list of com-
mon signs and symptoms of mild malaria in the guide-
lines of the National Malaria Control Programme [25]. All
scenarios did explicitly exclude signs of convulsions or
unconsciousness, which would be an indication for severe
disease. Mystery shoppers were trained to report only the
above listed symptoms to the vendors in the shops. For
the child-scenarios, the mystery shoppers would carry
their children when visiting the shops, if at all possible.
Local DSS field staff recruited mystery shoppers from the
villages in which the respective shops were located. On
the day of the study, the mystery shoppers were trained by
project staff on how to approach a shop, and which symp-
toms to report or not report. Mystery shoppers were asked
to visit one selected shop and ask for treatment based onBMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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the aforementioned case-scenario. Each mystery shopper
received 2,000 Tanzanian shilling (TSh) (US $1.80) to
buy drugs. After completing their assignment, they were
interviewed by project staff about what exactly happened
when they visited the shops, what they had told the shop-
keeper, and what advice and drugs they were given. Inter-
views were tape-recorded and later transcribed. Drugs and
remaining money were collected, types and amount of
drugs recorded, and the mystery shoppers were paid a
small allowance for their collaboration.
Data entry and analysis
Generic and brand names (if possible), as well as amount
and price of the drugs obtained by the mystery shoppers
were entered in a Microsoft Access database (Microsoft
Corp., Seattle, USA). Interviews with the mystery shoppers
were entered with word processing software in an RTF file
and imported into MAXqda software (VERBI GmbH, Mar-
burg, Germany) for coding of the answers. Statistical anal-
ysis was done with Intercooled Stata 9 (StataCorp, College
Station, Texas, USA).
Ethics
While mystery shoppers were fully informed and asked
for informed consent, the nature of this study did not
allow informing the shopkeepers in advance and asking
them for consent to participate. To protect shopkeepers'
privacy, no names of staff were recorded and names of
shops were never mentioned in connection with the
study's results. For the shop census, informed consent was
obtained from shopkeepers as described in detail in the
aforementioned publication.
The shop survey and mystery shopper study were granted
ethical clearance as part of the ACCESS Programme pro-
posal by the institutional review board of the Ifakara
Health Research and Development Centre and the Tanza-
nian National Medical Research Coordinating Committee
(NIMR/HQ/R.8a/Vol.IX/236).
Results
Shop census
The sample for this analysis included interviews with
shopkeepers of 29 part II drug stores and 460 general
shops, all of which stocked drugs the day of the interview.
General shopkeepers had on average a lower education
than their peers in drug stores (7 vs.10 years, P < 0.001).
A shopkeeper with medical or health-related qualifica-
tions was found in 93% of the drug stores and 2% of the
general shops (P < 0.001). Shopkeepers reported the
number of customers buying drugs per day to be on aver-
age 19 (95% CI 14–24) in drug stores and 10 (9–11) in
general shops (P < 0.001).
Knowledge of malaria symptoms and treatment
Shopkeepers of drug stores most frequently mentioned
fever, headache and vomiting (86% each) as symptoms of
malaria (not specified whether in children or adults). In
general shops, fever (60%), headache (40%) and joint
pains (39%) were most frequently mentioned (Table 1).
Generally, shopkeepers of general shops seemed to be sig-
nificantly less aware of malaria symptoms. They men-
tioned all of the recorded symptoms less frequently than
shopkeepers of drug stores. Out of 15 symptoms associ-
ated with malaria, shopkeepers in drug stores mentioned
on average 4.8 (95% CI 4.1 to 5.5), while in general shops
they mentioned only 2.4 (2.3–2.5) (P = 0.005). If asked
for "severe malaria" (in Swahili: malaria kali), a similar
picture arose. The symptoms most often mentioned by
general shopkeepers were high fever (44%) and weakness
(18%), while in drug stores, shopkeepers most often men-
tioned high fever (79%) and convulsions (degedege)
(52%) (Table 1).
In drug stores, most shopkeepers knew that an antimalar-
ial drug was the recommended treatment for malaria in a
two year-old child (90%) and in an adult (93%). In gen-
eral shops, shopkeepers most frequently said that the
child should be referred to a health facility (34%) while
adults should take an antimalarial drug (54%). Shopkeep-
ers of drugs stores had significantly better knowledge of
malaria treatment, as shown in Table 2. In drug stores,
66% mentioned SP as the recommended treatment for a
child aged two years and 79% for an adult. In general
shops this percentage was significantly lower. Of those
who mentioned SP, 79% (54–94) knew the correct child
dose in drug stores and 27% (16–40) in general shops (P
< 0.001). No shopkeeper mentioned traditional treat-
ment, or that the episode should not be treated at all.
In a multivariate logistic regression analysis adjusted for
shop type, number of customers and shop location,
higher general education was a significant predictor of
knowing SP as recommended treatment for adults (OR =
1.15, 95% CI 1.02–1.30; P = 0.020). A health-related
qualification was a strong predictor of knowing SP as a
child treatment (OR = 12.36, 2.45–62.20; P = 0.002). Cor-
rectly dosed SP for adults – but not for children – was cor-
related with higher education (OR = 1.15, 1.01–1.30; P =
0.032) and a health-related qualification (OR = 4.80,
1.08–21.34; P = 0.039). Generally, there seemed to be bet-
ter knowledge of the appropriate treatment among shop-
keepers in Ulanga DSS villages, compared to Kilombero
DSS and Ifakara town.
Referral
Shopkeepers were asked for situations in which they
would refer a customer to another outlet or a health facil-
ity. In drug stores, 19 or 66% (46–82) of the shopkeepersBMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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said they would refer customers if they showed signs of
severe malaria, in general shops this was indicated by 259
or 56% (52–61). Of the general shopkeepers, 58 or 13%
(10–16) said they would never refer somebody to another
outlet or a health facility, while this was never mentioned
by shopkeepers of drug stores.
Mystery shoppers
A total of 20 part II drug stores and 98 general shops were
visited by mystery shoppers. General shops comprised all
sorts of outlets, from permanent modern shops to tempo-
rary stalls. Case-scenarios were distributed as shown in
Figure 2.
Drug sale
Mystery shoppers obtained drugs in 53 (54%, 95% CI 62–
97) general shops and 17 (85%, 44–64) drug stores (P =
0.010) (Table 3).
Out of the 17 drug stores that sold drugs, 88% (64–99)
dispensed an antipyretic and the same percentage an anti-
malarial (Table 4). SP and amodiaquine were sold most
often. Antimalarials were usually sold together with para-
cetamol, a practice which is recommended for SP in the
national guidelines [25].
No antimalarials other than SP, amodiaquine or quinine
were dispensed and only two drug stores sold an antibi-
otic. In the Kilombero DSS villages, Vitamin B was some-
times dispensed together with antimalarials.
Of the 53 general shops, 85% (72–93) sold an antipy-
retic, usually paracetamol and 19% (9–32) sold an anti-
malarial, either SP or amodiaquine. About half of the
antimalarial dosages were sold together with paracetamol.
Two general shop sold an antibiotic (Table 4).
On average, drug stores sold more products per client than
general shops, which often had only paracetamol on offer.
Drug stores most frequently sold two products (to 44% of
the mystery shoppers) (mean 2.9 products, 95% CI 2.0 to
3.8). General shops most often sold only one product
(66% of the mystery shoppers) (mean 1.5 products, 1.2 to
1.8).
Table 1: Malaria symptoms mentioned most frequently by 
shopkeepers (N = 489)
Drug store General shop
Symptom % (95% CI) % (95% CI) P*
N2 9 4 6 0
What are symptoms of malaria?
Fever 86 (68–96) 60 (56–65) 0.006
Headache 86 (68–96) 40 (36–45) 0.000
Joint pains 62 (42–79) 39 (34–44) 0.014
Vomiting 86 (68–96) 33 (28–37) <0.001
Malaise 31 (15–51) 20 (16–24) 0.138
Feeling cold 17 (6–36) 16 13–20) 0.895
Poor appetite 21 (8–40) 10 (7–13) 0.063
Weakness 28 (13–47) 7 (5–10) <0.001
Diarrhoea 28 (13–47) 6 (4–8) <0.001
Dizziness 14 (4–32) 4 (2–6) 0.013
Don't know 0 (0–12) 12 (9–15) 0.053
What are symptoms of severe malaria?
Changed behaviour 24 (10–44) 17 (14–21) 0.326
Unconsciousness/coma 17 (6–36) 7 (5–10) 0.059
Weakness 35 (18–54) 18 (15–22) 0.027
Anaemia 10 (2–27) 1 (0–2) <0.001
Convulsions (degedege) 52 (33–71) 10 (7–13) <0.001
Splenomegaly (bandama) 3 (0–18) 0 (0–1) 0.008
High fever 79 (60–92) 44 (39–38) <0.001
Don't know 3 (0–18) 27 (23–32) 0.005
* Wilcoxon rank sign test
Table 2: Shopkeepers' understanding of the recommended 
treatment of uncomplicated malaria (N = 489)
Drug store General shop
Treatment‡ % (95% CI) % (95% CI) P*
N2 9 4 6 0
Child aged two years with uncomplicated malaria
Referral to health facility 3 (0–18) 34 (30–39) 0.001
Antipyretic 55 (36–74) 31 (27–35) 0.007
Antimalarial 90 (73–98) 32 (28–36) <0.001
- SP 66 (46–82) 12 (9–16) <0.001
- SP + PCM 35 (18–54) 5 (3–7) <0.001
- SP correct dose 52 (33–71) 3 (2–5) <0.001
- SP correct dose + PCM 31 (15–51) 1 (0–2) <0.001
Adult with uncomplicated malaria
Referral to HF† 0 (0–12) 24 (20–28) 0.003
Antipyretic 55 (36–74) 44 (39–49) 0.237
Antimalarial 93 (77–99) 54 (49–58) <0.001
- SP 79 (60–92) 35 (31–40) <0.001
- SP + PCM 48 (29–68) 16 (13–19) <0.001
- SP correct dose 76 (57–90) 29 (25–33) <0.001
- SP correct dose + PCM 45 (26–64) 14 (11–18) <0.001
SP = Sulphadoxine-pyrimethamine; PCM = Paracetamol.
* Wilcoxon rank sign test.
‡ Double-mentioning possible.
† one-sided, 97.5% confidence interval.BMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
Page 6 of 11
(page number not for citation purposes)
Predictors of drug sale
Univariate and multivariate models were fitted to assess
factors related to obtaining an antimalarial and obtaining
an antimalarial treatment according to Tanzanian guide-
lines.
Adjusted for the confounding effect of age group (i.e. case
scenarios A, B, C, as described above), visits to a drug store
resulted significantly more often in obtaining a drug than
visits to a general shop (OR = 6.02, 95% CI 1.57–23.10)
and shopkeepers in the DSS were more likely to sell a drug
than their counterparts in Ifakara (OR = 2.53, 1.04–6.18).
In drug stores, mystery shoppers were significantly more
likely to receive an antimalarial (OR = 76.47, 13.07–
447.50) (Table 5). Adults were more likely to be sold an
antimalarial compared with infants (OR = 9.30, 1.70–
50.92) and compared with the two child scenarios (OR =
11.27, 2.36–53.81) (not in table). There was no signifi-
cant difference in this outcome between shops located in
the villages or in Ifakara town.
In order to assess whether the observed difference in anti-
malarial dispensing was due to a lower availability of
drugs in general shops, the same analysis was carried out
only with shops that had dispensed any drugs at all. It
resulted that drug stores were again more likely to dis-
pense an antimalarial than general shops (OR = 70.71,
9.38–533.10). If a drug was sold, mystery shoppers were
in both types of shops equally likely to receive an antipy-
retic drug.
Adjusted for the same confounders as listed in Table 5,
mystery shoppers visiting a drug store were more likely to
receive the recommended first-line antimalarial SP (OR =
9.62; 1.53–60.53) or even SP together with paracetamol
(OR = 16.40; 2.28–117.99) than those who went to a gen-
eral shop.
Again, the same analysis was carried out only for those
shops that had dispensed an antimalarial. In this case,
drug stores did not dispense SP (or SP with paracetamol)
more often than general shops.
Flow-chart of mystery shoppers study Figure 2
Flow-chart of mystery shoppers study. Case scenarios: A = child, aged 2–4 months; B = child, aged 2–4 years; C = adult. 
Refer to main text for details.
Table 3: Number of shops that dispensed drugs to mystery 
shoppers
Drug store General shop Total
Area n/N (%) n/N (%) n/N (%)
Ulanga DSS 2/2 (100) 23/30 (77) 25/32 (78)
Kilombero DSS 10/10 (100) 20/44 (46) 30/54 (56)
Ifakara 5/8 (63) 10/24 (42) 15/32 (47)
Total 17/20 (85) 53/98 (54) 70/118 (59)BMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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Price
In drug stores, mystery shoppers paid a median price of
TSh 1000 or US $0.90 (interquartile range [IQR] 0.50–
1.53) for drugs, while in general shops they spent only
TSh 140 or US $0.13 (IQR 0.09–0.29, equality-of-medi-
ans test P < 0.001).
In a multivariate linear regression model we assessed the
effect of the age group (case scenario A, B, C), the number
of products sold, the shop type and the location (Ifakara
vs. DSS) on the price charged to the mystery shoppers. Sig-
nificantly less (-25%) money was spent for adult cases
(case scenario C) compared to children aged 2–4 months
(case scenario A) (P = 0.012) and 59% more in drug stores
than in general shops (P < 0.001). Obviously, more
money was spent if more drugs were sold (12% more per
additional product; P = 0.001) (Table 6).
Dosage and advice
The accuracy of the dosages was judged from the amount
of drugs the mystery shoppers obtained and from their
accounts of the advice they were given by the shopkeepers.
10/11 (91%) SP doses were tablets, one was a suspension.
4/10 (40%) amodiaquine doses were tablets and 6 were
suspensions. Quinine was sold 2/4 (50%) times as tablets,
and twice as syrup.
10/11 (91%) SP dosages (incl. the suspension) and 4/10
(40%) amodiaquine dosages (2 tablets, 2 suspensions)
were correct, considering the amount sold and the advice
given. For two amodiaquine doses, no dosage informa-
tion was available. Quinine tablets and syrup doses were
all wrongly dosed. With the low number of samples no
relevant comparison could be made between the appro-
priateness of the dosages and the shop types. Yet it should
be noted that in general stores, all SP dosages tablet were
correct, while in the drug stores, 1/6 was under-dosed
(adult case). On the other hand, all amodiaquine dosages
which were sold in drug stores (and for which the dosage
information was available) were correct while those sold
in general shops were under-dosed.
Table 4: Types of medicines sold to mystery shoppers
Drug stores General shops
N1 7 5 3
Type of drugs n % n %
Antimalarials
SP 6 35 5 9
Amodiaquine 6 35 4 8
Quinine 4 24 0
Any antimalarial 15 88 10 19
Antipyretics
Paracetamol 14 82 39 74
Any antipyretic 15 88 45 85
Other drugs
Antibiotic 2 12 2 4
Vitamin B complex 5 29 0
Combinations
SP & paracetamol 6 35 3 6
Amodiaquine & paracetamol 4 24 2 4
Quinine & paracetamol 4 24 0
SP & quinine 1 6 0
Antimalarial & antibiotic 2 12 0
Table 5: Univariate and multivariate logistic regression analysis of the relationship between (any) antimalarial drug obtained and 
selected predictors (all visited shops)
Univariate model Multivariate model
Predictor n Odds Ratio (95% CI) P* Odds Ratio (95% CI) P*
Case scenario
- Child 2–4 months 43 1 1
- Child 1–4 years 33 0.85 (0.22–3.30) 0.815 0.62 (0.09–4.00) 0.612
- Adult 42 3.43 (1.18–9.98) 0.024 9.30 (1.70–50.92) 0.010
Shop type
- General shop 98 1 1
- Drug store 20 26.40 (7.91–88.10) <0.001 76.47 (13.07–447.50) <0.001
Location
- Ifakara 32 1 1
- DSS 86 0.95 (0.35–2.53) 0.911 1.65 (0.41–6.66) 0.480
* Wald test of significance of effectBMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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3 (15%) drug stores and 29 (30%) general shops did not
sell any drugs to the mystery shoppers although they
would have had drugs in stock (Figure 1). In all of these
drug stores the mystery shoppers were advised to seek
treatment or advice from a health facility. In the general
shops, 86% (25/29) of the shopkeepers referred the mys-
tery shoppers to a higher level: 62% (18/29) to a health
facility and 31% (9/29) to a drug store (some of them to
both).
Discussion
The private retail sector plays a central role in the provi-
sion of malaria treatment in Tanzania. In rural areas, 68%
of the population live within 5 km of a health centre or a
dispensary (98% in urban areas) [15]. Yet, poor quality of
care, shortage of skilled providers, stock-outs of essential
drugs, and long waiting times [16,17] are challenges
which may drive patients to seek care (or at least buy
drugs) from more expensive non-governmental facilities,
or from drug stores. The private retail sector may comple-
ment health facility services where the facilities are unable
to deliver [14].
In the studies presented here, drug stores were more fre-
quently visited for drugs than general shops. In an earlier
study, general shops have been described as being impor-
tant treatment sources for fever/malaria, with 29% of fever
cases using this source of treatment. Yet, in terms of drug
volumes, general shops accounted for only 6–7% of all
antimalarial doses dispensed in the two study districts
[20]. However, general shops are important first contact
points of patients with a network of treatment providers.
They are numerous even in small villages and often more
easily accessible than drug stores or health facilities [24].
While not being legally allowed to dispense antimalarial
drugs, they are recognised in the national policy as one
component of the health care delivery structure [25,26].
Yet, their relatively poor knowledge of malaria and its
appropriate treatment supports the ban of antimalarial
drugs from these outlets. Surprisingly, only 60% of gen-
eral shopkeepers mentioned homa (fever) as a symptom of
malaria. In part, this may be explained by the parallel use
of homa as a term to describe a less severe febrile illness or
general malaise [27,28]. Knowing the correct treatment
was clearly a function of the shopkeeper's education,
which in general shops was lower than in drug stores.
However, general shopkeepers did not seem to be com-
pletely unaware of their limitations, as 34% of them men-
tioned referral to a health facility as the correct action for
a child with malaria.
Drug stores on the other hand are the lowest level of pro-
viders which is generally tolerated to dispense prescrip-
tion-only antimalarial drugs. Unfortunately, they often do
not reach out into small villages or remote areas [24].
Shopkeepers in drug stores were more knowledgeable
about malaria-related symptoms and malaria treatment
than their counterparts in general shops. This was corre-
lated with basic medical or health-related training, a pre-
requisite for shopkeepers of licensed part II drug stores
[29]. Nevertheless, their performance was not satisfactory,
with only 52% mentioning SP in the correct dosage as rec-
ommended treatment for children.
Knowledge vs. practice
In order to get a realistic picture of drug-sellers' perform-
ance, we used mystery shoppers; an approach which has
been applied frequently in market research, but rarely in a
public health context [30,31]. The main challenge of
applying this methodology in a rural setting, which is to
Table 6: Linear regression model of predictors of higher expenditures for antimalarial drugs
Univariate model Multivariate model
Risk factors n Estimated effect (95% CI) P* Estimated effect (95% CI) P*
Case scenario
- Child 2–4 months 20 1 1
- Child 1–4 years 22 -0.12 (-0.42 to 0.18) 0.423 -0.16 (-0.37 to 0.05) 0.124
- Adult 26 -0.15 (-0.44 to 0.13) 0.285 -0.25 (-0.45 to -0.06) 0.012
Number of products 68 0.19 (0.11 to 0.27) <0.001 0.12 (0.05 to 0.19) 0.001
Shop type
- General shop 50 1 1
- Drug store 18 0.75 (0.56 to 0.95) <0.001 0.59 (0.38 to 0.80) <0.001
Location
- Ifakara 15 1 1
- DSS 53 -0.11 (-0.39 to 0.17) 0.434 -0.06 (-0.24 to 0.13) 0.548
*Wald test of significance of effectBMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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find capable mystery shoppers within a certain village,
was tackled with the help of knowledgeable village-based
DSS field staff.
Daily shopkeepers' practices clearly reflected their level of
understanding of appropriate treatment, the current drug
regulations, as well as the low antimalarial availability in
general shops [24]. Antipyretics were frequently sold in
both, drug stores and general shops. Most drug stores
(88%) also sold antimalarials to the mystery shoppers. In
contrast, during a study conducted elsewhere in Tanzania
in which shopkeepers were under observation, only 17%
of febrile patients had received an antimalarial [9]. In gen-
eral shops, 19% of the mystery shoppers were sold an
antimalarial, which was more than expected based on the
shop census in which 8% of all general shops that had
drugs in stock also stocked an antimalarial [24].
While many shopkeepers in drug stores knew that SP was
the recommended treatment for children and adults, in
practise, amodiaquine and quinine were sold as often as
SP. This may to some extent reflect that amodiaquine was
slightly more readily available in drug stores and, accord-
ing to anecdotal evidence, quinine was popular as it was
often regarded a strong and powerful medicine [24].
Overall, it was more likely that a mystery shopper received
an antimalarial or even SP in a drug store. However, drug
stores did not adhere better to the guidelines than general
shops. In part, this may be attributed to the larger choice
of products in drug stores. Mere non-availability may also
be a reason why no other antimalarials than SP, amodi-
aquine and quinine were sold, along with the fact that
with the cash provided by the researchers, the mystery
shoppers would not have been able to purchase expensive
drugs such as artemisinin mono therapies or ACT [32].
Altogether, adults would more readily be dispensed an
antimalarial than children. This is interesting in the light
of findings from a cross-sectional community-survey in
which adults would be treated more frequently with shop
bought drugs while children were more often brought to
a health facility [14]. This may give some indications of
provider-side influences on treatment-seeking behaviour.
Treatments for adults were 25% cheaper than treatments
obtained for very young children and drug stores were
more expensive than general shops. The latter was also
found in another study in the same area, where more
expensive treatments were obtained from non-govern-
mental organisation (NGO) facilities and drug stores,
usually by people from the better-off socio-economic stra-
tum [33].
Private retailers may commonly be perceived as being
mainly business-driven in their behaviour. In this study
we found that in theory, more than half of all shopkeepers
said they would refer severely ill patients and general
shopkeepers commonly regarded referral as best option
for young children. In practice, 15% (3/20) of drug stores
and 31% (25/82) of general shops did not sell any medi-
cines but referred the simulated patients to a higher level
of care – although they would have had drugs in their
shops. The awareness of shopkeepers that certain cases
need to be dealt with at a higher level may be a good entry
point for interventions targeted at the retailer level. Sev-
eral projects targeting private drug retailers, have already
counted on the ability and willingness of shopkeepers to
refer severe or complicated cases to an appropriate facility
[13,34].
Implications for policy and interventions
The importance of the retail sector as a source of malaria
treatment and care complementary to health facility has
been recognised internationally [35] and within Tanzania
[26]. However, the major concern regarding the private
sector has been inadequacy of the treatments offered by
often untrained (or not sufficiently trained) shopkeepers
[3,34,36]. This issue has re-emerged in the discussions
about appropriate delivery channels for ACTs. Defining
the role of each type of retailer present in a health system
within the frame of their capabilities and the given legal
context is an important first step in improving quality and
access.
Fully-fledged pharmacies only reach 17% of the Tanza-
nian population and are hence not sufficient to meet the
demand for essential drugs [37]. Part II drug stores which
are the largest network of licensed drug-retailers in Tanza-
nia [18] are licensed to sell only OTC drugs, to which
none of the recommended antimalarials belongs. Kachur
et al. showed that patients at drug stores are as likely to be
infected with malaria as patients seeking care at health
facilities [9]. Considering this demand for antimalarial
treatments, there is a need to make efficacious antimalar-
ial drugs available in drug stores. In reality this is usually
tolerated by the authorities who recognise the lack of
alternatives. In order to improve the quality of services in
drug stores, specialised training for drug vendors may be
a valid option for improving management of malaria-
cases, as has been shown in other areas [12]. The mere def-
inition of educational prerequisites as currently the case
for part II shops may only lure health workers away from
health facilities to a more profitable business in the retail
sector. Yet, training alone is unlikely to improve perform-
ance if not coupled with appropriate means of rewarding
the shopkeepers for good practices [36,38]. These
approaches are combined in a project that upgrades part
II shops and potentially general shops to Accredited Drug
Dispensing Outlets (ADDO) and that is currently being
implemented in selected districts in Tanzania [13,37].BMC Public Health 2008, 8:157 http://www.biomedcentral.com/1471-2458/8/157
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The role of general shops should not be the dispensing of
prescription medicines. Yet, due to their importance as
easily accessible first contact point for malaria patients,
they should not be completely left aside when targeting
the private sector. There are several options to strengthen
their role in the health sector. Firstly, they could be
upgraded to drug retailers (e.g. ADDOs) if appropriately
trained, thereby increasing the population coverage with
antimalarial providers. Secondly, general shopkeepers
could be trained on the appropriate first aid for malaria
cases with OTC medicines and subsequent referral to a
higher level. Considering that general shops may manage
malaria cases only with antipyretics, particularly in places
where they are the nearest provider, targeted information
or training may decrease the number of inappropriately
managed cases at the lowest level. The social pressure
exerted on shopkeepers by communities' expectations on
their performance should not be under-estimated. In our
study, a considerable number of shopkeepers did without
business in favour of referring the patient to a drug store
or a health facility.
Including all levels of formal and informal health care
providers is feasible within the existing legal framework
and guided by the national malaria control policy. Alter-
native approaches including lowest level shops may be a
step forward in improving access for people living in
remote areas or deprived villages which so far lack any
provider of antimalarial medicines [24].
Conclusion
Private retailers play an important role in the provision of
prompt and effective malaria treatment, complementing
the services of formal health facilities. Yet, the quality of
case-management in the retail sector leaves much room
for improvement. Drug stores should be empowered and
encouraged to provide correct malaria-treatment with
drugs they are legally allowed to dispense. At the same
time, the role of general shops as important first contact
points for malaria patients needs to be re-considered
within the given legal framework.
Interventions on shop-level should consider all types of
private retailers. While antimalarial medicines, such as
ACTs ought to be dispensed only by qualified personnel,
general shopkeepers may acquire sufficient knowledge to
properly recognise malaria cases and refer them to a
trained provider.
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